Table 3 Univariate and multivariable logistic regression analyses of different underlying factors for the development of pneumocystis infection.
From: Pneumocystis jirovecii pneumonia in HIV-uninfected, rituximab treated non-Hodgkin lymphoma patients
Risk factor | Simple regression | Multiple regression | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Rituximab | 2.33 | (1.75ā3.09) | <0.0001 | 2.47 | (1.84ā3.3) | <0.0001 |
Gender (Male) | 1.41 | (1.11ā1.8) | 0.0057 | 1.51 | (1.18ā1.94) | 0.001 |
Age (y) | ||||||
Ā Ā 45ā60 vs.āā¤ā45 | 1.11 | (0.8ā1.52) | 0.544 | 0.95 | (0.69ā1.32) | 0.7687 |
Ā Ā 60ā70 vs. ā¤45 | 1.27 | (0.9ā1.79) | 0.1726 | 1.07 | (0.75ā1.54) | 0.709 |
Ā Ā >70 vs.ā¤45 | 0.98 | (0.69ā1.37) | 0.8867 | 0.83 | (0.57ā1.22) | 0.3412 |
COPD | 0.87 | (0.67ā1.12) | 0.2786 | 0.9 | (0.69ā1.18) | 0.4413 |
RD | 0.97 | (0.73ā1.3) | 0.8535 | 1.07 | (0.79ā1.45) | 0.6751 |
DM | 0.88 | (0.65ā1.2) | 0.4214 | 0.87 | (0.63ā1.19) | 0.3796 |
CKD | 0.64 | (0.37ā1.12) | 0.1159 | 0.65 | (0.37ā1.15) | 0.1357 |